R. Khalil
Molecular Biology · Biochemical Pharmacology · 2001–2019
A researcher in the Science corpus: 7 papers; trusts 19 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 107 citations into it
- Cancer Research — 93 citations into it; #1,424 of 1,780 by trust here, #1,445 by citations
- Oncology — 93 citations into it; #1,571 of 1,698 by trust here, #1,557 by citations
- Immunology and Allergy — 73 citations into it
- Hematology — 41 citations into it; #181 of 225 by trust here, #163 by citations
- Genetics — 33 citations into it
- Cardiology and Cardiovascular Medicine — 30 citations into it
- Immunology — 29 citations into it
Whom R. Khalil trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- C. Blobel
- Gillian Murphy
- S. Coughlin
- Hideaki Nagase
- S. Apte
- W. Nelson
- Zena Werb
- A. Colige
- D. Edwards
Who trusts R. Khalil overall
Papers from R. Khalil's perspective
Ordered by how strongly the researchers R. Khalil trusts endorse each paper. Same corpus, a different order for every researcher.
- The ADAMs family of metalloproteases: multidomain proteins with multiple functions.
- The ADAMTS metalloproteinases.
- An essential role for ectodomain shedding in mammalian development.
- ADAMs: key components in EGFR signalling and development
- TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)*
- A metalloprotease-disintegrin participating in myoblast fusion
- Potential Role for ADAM15 in Pathological Neovascularization in Mice
- Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations (Science)
- Catalytic Properties of ADAM19*
Their papers
- A Disintegrin and Metalloproteinase (ADAM) and ADAM with Thrombospondin Motifs (ADAMTS) Family in Vascular Biology and Disease (2019) — 97 citations
- Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. (2018) — 586 citations
- Biochemical and Biological Attributes of Matrix Metalloproteinases (2017) — 1,059 citations
- Inflammatory Cytokines in Vascular Dysfunction and Vascular Disease (2009) — 1,314 citations
- Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. (2008) — 766 citations
- Gender, sex hormones, and vascular tone. (2004) — 680 citations
- Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. (2001) — 686 citations